<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Assessment of nutritional status in patients on hemodialysis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Assessment of nutritional status in patients on hemodialysis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Assessment of nutritional status in patients on hemodialysis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shweta Bansal, MD, FASN</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Monique E Cho, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Srinivasan Beddhu, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steve J Schwab, MD, FACP, FASN</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 31, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1266112796"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Patients on dialysis are commonly depleted of protein and energy stores [<a href="#rid1">1-5</a>]. The degree to which protein and energy depletion is the result of deficient nutrition or, alternatively, protein and energy wasting is unclear. In 2009, the International Society of Renal Nutrition and Metabolism (ISRNM) recommended the terminology protein-energy wasting (PEW) syndrome to describe the loss of body protein mass and fuel reserves in patients with end-stage kidney disease (ESKD) [<a href="#rid6">6</a>].</p><p>The assessment of nutritional status is a routine part of the care of patients on maintenance dialysis in order to allow early recognition and treatment of PEW syndrome. Markers of PEW are among the strongest predictors of morbidity and mortality in patients with ESKD [<a href="#rid3">3,7</a>].</p><p>This topic reviews our approach to the assessment of nutritional status among hemodialysis patients. The pathogenesis and treatment of PEW among hemodialysis patients are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1856.html" rel="external">"Pathogenesis and treatment of malnutrition in patients on maintenance hemodialysis"</a>.)</p><p>The assessment of nutritional status and the prevention and treatment of malnutrition among peritoneal dialysis patients are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1855.html" rel="external">"Nutritional status and protein intake in patients on peritoneal dialysis"</a>.)</p><p class="headingAnchor" id="H3184689553"><span class="h1">OUR APPROACH TO THE CLINICAL ASSESSMENT OF NUTRITIONAL STATUS</span><span class="headingEndMark"> — </span>We perform monthly nutritional assessments of all hemodialysis patients. Our approach includes a dietary assessment, physical examination, and laboratory examination.</p><p>Our approach is detailed here.</p><p class="headingAnchor" id="H2791307412"><span class="h2">Dietary assessment</span><span class="headingEndMark"> — </span>We question patients monthly about loss of appetite, loss of weight, or development of gastrointestinal symptoms such as nausea or vomiting. We inquire as to psychosocial issues such as access and affordability of food, ability to prepare meals, and the role of family members in food preparation.</p><p>We do <strong>not </strong>routinely conduct three-day dietary recalls to assess adequacy of nutrient intake as is recommended by the Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines [<a href="#rid8">8</a>]. Dietary recall is burdensome to staff and patients and relies on patient memory and compliance with recording. Furthermore, there is no randomized, controlled trial evidence to support this intensive strategy. We believe the protein nitrogen appearance (PNA), which is calculated using pre- and postdialysis blood urea nitrogen (BUN), is a better indicator of protein intake and subject to less measurement error then dietary diaries. (See <a class="local">'Urea nitrogen and protein nitrogen appearance'</a> below.)</p><p>An exception may be made among patients with difficult-to-control hyperkalemia or hyperphosphatemia; in such patients, dietary recall may be helpful.</p><p>We are vigilant regarding signs or symptoms of depression since clinical depression often results in a disinterest and decrease in caloric intake. (See  <a class="medical medical_review" href="/z/d/html/4855.html" rel="external">"Psychiatric illness in adults receiving maintenance dialysis", section on 'Major depression'</a>.)</p><p>The clinician should be aware of the presence of concomitant problems that can affect nutrition, such as alcoholism, diabetes mellitus gastrointestinal disease, and dental disorders [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H278381427"><span class="h2">Physical assessment</span><span class="headingEndMark"> — </span>We measure postdialysis edema-free weight every month. We use the weight to calculate the body mass index (BMI) and to monitor for weight loss. Given the dependency of the weight on the height, BMI is a better measurement of body mass than body weight alone [<a href="#rid10">10</a>]. In some patients who cannot achieve postdialysis euvolemia for a variety of reasons, we monitor the trend of their weight with simultaneous assessment of interdialytic weight gain and volume.</p><p>We do not use an adjusted body weight (ie, express actual weight as a percentage of standard body weight determined from the National Health and Nutrition Examination Survey [NHANES] II), which has been suggested to better define nutritional needs [<a href="#rid11">11</a>]. The impact of adjusted body weight on clinical outcomes has not been adequately studied.</p><p>As in the general population, a low BMI or unintentional weight loss are consistent predictors of poor outcome and high death risk in maintenance dialysis patients [<a href="#rid12">12,13</a>]. </p><p>The BMI threshold that indicates protein-energy wasting (PEW) is not known with certainty. The International Society of Renal Nutrition and Metabolism (ISRNM) panel recommends that a BMI less than 23 kg/m<sup>2</sup> is a marker of PEW in the dialysis population. However, the accuracy of this threshold is influenced by race and ethnicity. In particular, this BMI may not indicate a pathologic state among patients of East Asian descent [<a href="#rid14">14,15</a>].</p><p>Unintentional weight loss or reduction in BMI of any degree suggests the presence of PEW in dialysis patients. The ISRNM panel recommends that a loss of 5 percent of nonedematous weight within three months or an unintentional loss of 10 percent of nonedematous weight over six months should be considered an indicator of PEW independently of weight-for-height measures. A decline in BMI over time may be associated with increased mortality [<a href="#rid16">16</a>].</p><p>We do not measure skinfold thickness or mid-arm circumference (MAC) in routine clinical practice.</p><p class="headingAnchor" id="H2013417577"><span class="h2">Laboratory assessment</span><span class="headingEndMark"> — </span>We measure the serum albumin and pre- and postdialysis BUN monthly. We use the BUN to calculate the PNA. (See <a class="local">'Serum albumin'</a> below and <a class="local">'Urea nitrogen and protein nitrogen appearance'</a> below.)</p><p>We do not use any other laboratory measurements for routine nutritional assessment. Although multiple other measures are available, the practical utility of these tests in routine clinical practice is unclear. (See <a class="local">'Other methods'</a> below.)</p><p class="headingAnchor" id="H622199918"><span class="h3">Serum albumin</span><span class="headingEndMark"> — </span>A serum albumin &lt;3.8 g/dL is a suggested diagnostic criterion for PEW syndrome  (<a class="graphic graphic_table graphicRef67264" href="/z/d/graphic/67264.html" rel="external">table 1</a>) [<a href="#rid6">6</a>].</p><p>However, this threshold has not been validated as a measure of either protein or energy wasting. It is possible that a more stringent threshold would be a better indicator of wasting, although this requires study.</p><p>The serum albumin levels is widely used to assess the nutritional status of individuals with and without chronic kidney disease (CKD). The serum albumin levels generally correlate with changes in dietary protein intake [<a href="#rid17">17</a>].</p><p>A low serum albumin is one of the strongest predictors of outcomes in CKD and dialysis patients [<a href="#rid10">10,18,19</a>]. However, serum albumin levels may also fall due to non-nutritional factors including inflammation, acute or chronic stress, overhydration, urinary or peritoneal losses, and acidemia [<a href="#rid20">20-22</a>]. It may not be possible to delineate whether the nutritional component or other non-nutritional factors that are associated with hypoalbuminemia are responsible for the higher mortality.</p><p>It is important to be aware of the method used to measure albumin since different methods yield different results, specifically among end-stage kidney disease (ESKD) patients.</p><p>The gold-standard method for the measurement of serum albumin is nephelometry. However, nephelometry is not commonly used in clinical practice, since it is a costly and tedious procedure. Serum albumin is more commonly measured by either bromocresol green method or bromocresol purple method. Among ESKD patients, albumin estimation by bromocresol green method more closely estimates values obtained by nephelometry, whereas the bromocresol purple method underestimates the albumin concentration [<a href="#rid23">23-25</a>]. This is different from patients without ESKD in whom the bromocresol purple method is more accurate [<a href="#rid24">24,26</a>].</p><p class="headingAnchor" id="H2833701383"><span class="h3">Urea nitrogen and protein nitrogen appearance</span><span class="headingEndMark"> — </span>Malnourished patients often show a gradual reduction in BUN. Low predialysis BUN levels have been associated with increased mortality [<a href="#rid27">27</a>].</p><p>However, in addition to protein intake, BUN levels are affected by residual kidney function and adequacy of dialysis. The PNA calculated from the BUN better estimates protein intake in the stable patients. (See  <a class="medical medical_review" href="/z/d/html/1841.html" rel="external">"Protein intake in patients on maintenance hemodialysis"</a>.)</p><p>The PNA is calculated from the post- and predialysis BUN concentrations of two consecutive hemodialysis sessions. The rate of increase in serum urea nitrogen between two consecutive hemodialysis sessions reflects dietary nitrogen intake, provided that the individual is not in substantially negative or positive nitrogen balance (or, in other words, neither catabolic nor anabolic) and providing the patient does not have significant residual kidney function. Among patients with residual kidney function, total urea lost in the urine must also be measured from urine collected during the interdialytic period. (See  <a class="medical medical_review" href="/z/d/html/1841.html" rel="external">"Protein intake in patients on maintenance hemodialysis", section on 'Calculation'</a>.)</p><p>In well-dialyzed patients, a PNA &lt;1.2 g/kg/day suggests poor nutrient intake or signals the onset of an intercurrent illness. PNA may overestimate daily protein intake when the protein intake is less than 1 g/kg/day (possibly due to endogenous protein catabolism) [<a href="#rid28">28-30</a>].</p><p>National guidelines (based on opinion) recommend maintaining a PNA &gt;1.2 g/kg/day [<a href="#rid31">31,32</a>].</p><p class="headingAnchor" id="H1589884475"><span class="h1">DIAGNOSIS OF PROTEIN-ENERGY WASTING</span><span class="headingEndMark"> — </span>We believe that the diagnosis of protein-energy wasting (PEW) is suggested by any progressive decrease in body mass index (BMI), albumin, and protein nitrogen appearance (PNA) rather than by a defined threshold in any parameter. Specific indications for treatment and our approach to the treatment of PEW are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1856.html" rel="external">"Pathogenesis and treatment of malnutrition in patients on maintenance hemodialysis"</a>.)</p><p>Several criteria have been proposed for the diagnosis of PEW [<a href="#rid6">6</a>]. However, we do not recommend using these criteria for routine clinical practice, as they have not been validated for the diagnosis of PEW, and using criteria has not been shown to improve clinical outcomes. These proposed criteria are discussed below:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>International Society of Renal Nutrition and Metabolism – </strong>The International Society of Renal Nutrition and Metabolism (ISRNM) expert panel recommends that four categories be recognized for the diagnosis of PEW, including biochemical criteria; low body weight, reduced total body fat, or weight loss; a decrease in muscle mass; and low protein or energy intakes  (<a class="graphic graphic_table graphicRef110259" href="/z/d/graphic/110259.html" rel="external">table 2</a>) [<a href="#rid6">6</a>]. At least three out of the four listed categories (and at least one test in each of the selected category) must be satisfied for the diagnosis of PEW. Optimally, each criterion should be documented on at least three occasions, preferably two to four weeks apart.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subjective global assessment – </strong>Subjective global assessment (SGA) is based on subjective and objective aspects of the patient’s medical history and physical examination and can be performed rapidly without need for much training [<a href="#rid33">33</a>]. In brief, four items are scored. These items include a change in dry body weight, a change in dietary intake and gastrointestinal symptoms, a decrease of subcutaneous fat, and muscle atrophy. </p><p></p><p class="bulletIndent1">Patients are subjectively scored from 1 (severely malnourished) to 7 (well nourished). A fair intra- and inter-rater reliability and validity of SGA have been demonstrated in end-stage kidney disease (ESKD) population [<a href="#rid34">34-36</a>], and it has shown to be predictive of mortality [<a href="#rid36">36-38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>French protein-energy wasting score</strong> – The French PEW score grades one selected item in each of the four categories of the wasting syndrome  (<a class="graphic graphic_table graphicRef67264" href="/z/d/graphic/67264.html" rel="external">table 1</a>). The selected items include serum albumin (for serum chemistry), body mass index (BMI; for body mass), predialysis serum creatinine normalized by body surface area (for muscle mass), and normalized protein nitrogen appearance (PNA; for dietary intake) [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1">In a three-year dialysis follow-up cohort including 1443 patients, there was a reduction in survival for each unit decrement in the score grade. In addition, the six-month variation of this PEW score strongly predicted patients' survival [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mini Nutritional Assessment</strong> – The Mini Nutritional Assessment short form (MNA-SF) score consists of six short sections that can easily and quickly be completed in clinic. Categories include food intake, weight loss, mobility, recent psychological stress or acute disease, neuropsychological problems, and BMI (www.mna-elderly.com/sites/default/files/2021-10/mna-mini-english.pdf). In a study of 216 patients on dialysis, the MNA-SF identified inadequately nourished (ie, either at risk for malnutrition or malnourished) patients with a sensitivity, specificity, and negative predictive value of 0.95, 0.63, and 0.91, respectively. The MNA-SF score also was associated with mortality [<a href="#rid40">40</a>]. </p><p></p><p class="headingAnchor" id="H269901298"><span class="h1">OTHER METHODS</span><span class="headingEndMark"> — </span>Multiple other measures have been used for nutritional assessment. The practical utility of these tests in routine clinical practice is unclear. Commonly used tests are discussed here:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prealbumin </strong>– The plasma concentration of prealbumin (transthyretin) varies with the state of nutrition in patients with normal kidney function [<a href="#rid41">41</a>]. However a single value may not be an accurate predictor of nutrition among end-stage kidney disease (ESKD) patients, since prealbumin is normally excreted and metabolized by the kidney and accumulates in kidney failure [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1">Serial measurements can be monitored once a baseline level has been established for the individual patient. Prealbumin concentrations change rapidly in response to alterations in nutritional status and can be used to assess the response to nutritional interventions.</p><p></p><p class="bulletIndent1">In addition to nutritional status, low prealbumin levels may also reflect an acute intercurrent illness. One study also found that decreased prealbumin levels correlated independently with increased mortality and hospitalization due to infection [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serum transferrin </strong>– Among hemodialysis patients, transferrin correlates with nutritional status independent of patient age, dialysis vintage, iron status, or other hemoglobin-related factors [<a href="#rid44">44</a>]. Transferrin also correlates with clinical outcome [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serum cholesterol </strong>– The plasma cholesterol concentration is reduced in malnourished hemodialysis patients. In this setting, there is an inverse relationship between mortality and the cholesterol concentration [<a href="#rid7">7,46</a>]. Cholesterol may be influenced by the same comorbid conditions, such as inflammation, that affect other nutritional markers (eg, serum albumin) [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serum creatinine </strong>– As creatinine is produced by muscle, serum creatinine is an indicator of muscle mass in hemodialysis patients. However, in addition to muscle mass, meat intake, residual kidney function, and nonrenal excretion through the gastrointestinal tract affect serum creatinine levels. Furthermore, the threshold level of serum creatinine that indicates malnutrition has not been defined.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Waist or hip circumference or waist-to-hip ratio (WHR) </strong>– These indicators of abdominal obesity reflect the risk associated with excessive visceral fat, which is the most relevant fat compartment for cardiovascular risk [<a href="#rid47">47-49</a>]. Waist circumference measurement is particularly useful in patients who are categorized as normal or overweight, but not obese, on the body mass index (BMI) scale. At BMIs greater than or equal to 35 (ie, obese individuals), waist circumference adds little predictive power of disease risk to the BMI.</p><p></p><p class="bulletIndent1">Waist circumference (WHR) is measured over the unclothed abdomen just above the iliac crest, and hip circumference is measured at the level of the widest diameter around the buttocks [<a href="#rid50">50</a>]. A strong association among waist circumference, WHR, and cardiovascular risk factors has been demonstrated in chronic kidney disease (CKD) and dialysis patients [<a href="#rid51">51</a>]. In a study cohort of 537 dialysis patients, after adjustment of BMI, every 10 cm increase in waist circumference was associated with 49 percent increased risk of all-cause mortality and 55 percent increased risk of cardiovascular mortality [<a href="#rid52">52</a>]. Every increase in WHR by 0.1 was associated with 25 percent increased risk of mortality [<a href="#rid52">52</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Body composition </strong>– Assessment of body compartments such as fat mass, muscle mass, and bone mass can contribute to better understanding of the role of nutritional variables in clinical outcomes in dialysis patients. The techniques that are used to assess body composition include anthropometry, creatinine kinetics, bioimpedance analysis (BIA), dual-energy x-ray absorptiometry (DXA), computed tomography (CT), or magnetic resonance imaging (MRI).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Anthropometry </strong>– Anthropometry is simple and quick to carry out but is not as accurate as more sophisticated techniques. Commonly used measurements include mid-arm muscle circumference, which estimates muscle mass at the mid-arm level, and skinfold thickness, which may be used to estimate total body fat percentage [<a href="#rid53">53</a>].</p><p></p><p class="bulletIndent2">Anthropometry is most useful if serial measurements are carried out by the same observer. Inability to do this limits its utility. More sophisticated measures of body composition described below have largely superseded anthropometry.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bioimpedance analysis </strong>– BIA is relatively inexpensive, easy to use, noninvasive, portable, and requires little operator training to be performed [<a href="#rid54">54,55</a>]. BIA measures impedance or resistance to the flow of an electrical current within the body, which is used to determine total body water and can distinguish muscle mass from fat.</p><p></p><p class="bulletIndent2">However, as BIA uses estimation of water content to calculate muscle mass, volume status could influence the results.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Dual-energy x-ray absorptiometry </strong>– DXA is a reliable and noninvasive method to assess the three main components of body composition (fat mass, fat-free mass, and bone mineral mass and density) [<a href="#rid56">56</a>]. DXA has been validated in CKD and dialysis patients [<a href="#rid57">57-59</a>]. Similar to BIA, estimation of muscle mass may be affected by hydration status. Additional limitations are the use of irradiation, cost, need for dedicated space for the equipment, and travel to the facility.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Creatinine kinetics </strong>– Creatinine kinetics may be used as an indicator of muscle mass, although interpretation may be limited by residual kidney function [<a href="#rid5">5</a>]. Creatinine kinetics are laborious and not widely used.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging techniques </strong>– Imaging techniques such as whole-body CT or MRI scans can be used to quantitate whole body muscle mass but are expensive to perform [<a href="#rid60">60</a>]. Thigh images have been used to estimate thigh muscle area/mass as an indicator of whole body muscle mass [<a href="#rid61">61</a>]. A single MRI scan at L4-L5 level may be used to estimate visceral fat area and lean body mass [<a href="#rid61">61,62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Muscle strength </strong>– Muscle strength may be a stronger predictor of mortality than absolute muscle mass [<a href="#rid63">63</a>]. However, performance on muscle strength tests may be affected by age, cognition, medications (such as sedatives), smoking, alcohol consumption, etc [<a href="#rid64">64</a>].</p><p></p><p class="headingAnchor" id="H662742881"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Protein-energy wasting syndrome</strong> – Dialysis patients are commonly depleted of protein and energy stores as a result of either deficient nutrition or protein and energy wasting. The term protein-energy wasting (PEW) syndrome describes the loss of body protein mass and fuel reserves in patients with end-stage kidney disease (ESKD). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical assessment of nutritional status</strong> – We perform monthly nutritional assessments of all hemodialysis patients. Our approach includes a dietary assessment, physical examination, and laboratory examination. We do <strong>not </strong>routinely conduct three-day dietary recalls to assess adequacy of nutrient intake. (See <a class="local">'Dietary assessment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Physical assessment</strong> – We monitor postdialysis edema-free weight every month for evidence of weight loss and to calculate the body mass index (BMI). A low BMI or unintentional weight loss suggests PEW and is a predictor of poor outcome and high death risk in maintenance dialysis patients. (See <a class="local">'Physical assessment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laboratory assessment</strong> – We measure the serum albumin and pre- and postdialysis blood urea nitrogen (BUN) monthly. We use the BUN to calculate the protein nitrogen appearance (PNA). We do not use any other laboratory measurements for routine nutritional assessment. (See <a class="local">'Laboratory assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis of protein-energy wasting</strong> – The diagnosis of PEW is suggested by any progressive decrease in BMI, albumin, and PNA. Although several criteria have been proposed for the diagnosis of PEW, we do not use these criteria for routine clinical practice, since their use has not been shown to improve clinical outcomes in dialysis patients. Furthermore, while these criteria have been empirically developed, the validity of these criteria for protein or energy wasting needs to be established. (See <a class="local">'Diagnosis of protein-energy wasting'</a> above.)</p><p></p><p class="headingAnchor" id="H2868400212"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The editorial staff at UpToDate acknowledge Marsha Wolfson, MD, FACP, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Thunberg BJ, Swamy AP, Cestero RV. Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 1981; 34:2005.</a></li><li><a class="nounderline abstract_t">Schoenfeld PY, Henry RR, Laird NM, Roxe DM. Assessment of nutritional status of the National Cooperative Dialysis Study population. Kidney Int Suppl 1983; :S80.</a></li><li><a class="nounderline abstract_t">Owen WF Jr, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329:1001.</a></li><li><a class="nounderline abstract_t">Aparicio M, Cano N, Chauveau P, et al. Nutritional status of haemodialysis patients: a French national cooperative study. French Study Group for Nutrition in Dialysis. Nephrol Dial Transplant 1999; 14:1679.</a></li><li><a class="nounderline abstract_t">Keshaviah PR, Nolph KD, Moore HL, et al. Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994; 4:1475.</a></li><li><a class="nounderline abstract_t">Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73:391.</a></li><li><a class="nounderline abstract_t">Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15:458.</a></li><li><a class="nounderline abstract_t">Wolfson M. Management of protein and energy intake in dialysis patients. J Am Soc Nephrol 1999; 10:2244.</a></li><li><a class="nounderline abstract_t">Akar H, Akar GC, Carrero JJ, et al. Systemic consequences of poor oral health in chronic kidney disease patients. Clin J Am Soc Nephrol 2011; 6:218.</a></li><li><a class="nounderline abstract_t">Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993; 44:115.</a></li><li><a class="nounderline abstract_t">Kopple JD, Jones MR, Keshaviah PR, et al. A proposed glossary for dialysis kinetics. Am J Kidney Dis 1995; 26:963.</a></li><li><a class="nounderline abstract_t">Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis 2003; 41:925.</a></li><li><a class="nounderline abstract_t">Kalantar-Zadeh K, Abbott KC, Salahudeen AK, et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81:543.</a></li><li><a class="nounderline abstract_t">Stevens J, Nowicki EM. Body mass index and mortality in asian populations: implications for obesity cut-points. Nutr Rev 2003; 61:104.</a></li><li><a class="nounderline abstract_t">Wong JS, Port FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999; 55:2515.</a></li><li><a class="nounderline abstract_t">Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 2005; 46:489.</a></li><li class="breakAll">Keys ABJ, Henschel A, Mickelsen O, Taylor HL. The Biology of Human Starvation, University of Minnesota, Minneapolis 1950.</li><li><a class="nounderline abstract_t">Beddhu S, Kaysen GA, Yan G, et al. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis 2002; 40:721.</a></li><li><a class="nounderline abstract_t">Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005; 20:1880.</a></li><li><a class="nounderline abstract_t">Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29:658.</a></li><li><a class="nounderline abstract_t">Ballmer PE, McNurlan MA, Hulter HN, et al. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J Clin Invest 1995; 95:39.</a></li><li><a class="nounderline abstract_t">Han DS, Lee SW, Kang SW, et al. Factors affecting low values of serum albumin in CAPD patients. Adv Perit Dial 1996; 12:288.</a></li><li><a class="nounderline abstract_t">Wells FE, Addison GM, Postlethwaite RJ. Albumin analysis in serum of haemodialysis patients: discrepancies between bromocresol purple, bromocresol green and electroimmunoassay. Ann Clin Biochem 1985; 22 ( Pt 3):304.</a></li><li><a class="nounderline abstract_t">Maguire GA, Price CP. Bromcresol purple method for serum albumin gives falsely low values in patients with renal insufficiency. Clin Chim Acta 1986; 155:83.</a></li><li><a class="nounderline abstract_t">Joseph R, Tria L, Mossey RT, et al. Comparison of methods for measuring albumin in peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1996; 27:566.</a></li><li><a class="nounderline abstract_t">Pinnell AE, Northam BE. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem 1978; 24:80.</a></li><li><a class="nounderline abstract_t">Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis 1993; 21:125.</a></li><li><a class="nounderline abstract_t">Panzetta G, Tessitore N, Faccini G, Maschio G. The protein catabolic rate as a measure of protein intake in dialysis patients: usefulness and limits. Nephrol Dial Transplant 1990; 5 Suppl 1:125.</a></li><li><a class="nounderline abstract_t">Lorenzo V, de Bonis E, Rufino M, et al. Caloric rather than protein deficiency predominates in stable chronic haemodialysis patients. Nephrol Dial Transplant 1995; 10:1885.</a></li><li><a class="nounderline abstract_t">Chauveau P, Naret C, Puget J, et al. Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor. Nephrol Dial Transplant 1996; 11:1568.</a></li><li><a class="nounderline abstract_t">Eknoyan G, Levin NW, Steinberg EP. The dialysis outcomes quality initiative: history, impact, and prospects. Am J Kidney Dis 2000; 35:S69.</a></li><li class="breakAll">Rationale and methods for the determination of the protein equivalent of nitrogen appearance (PNA). 2000.</li><li><a class="nounderline abstract_t">Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr 1987; 11:8.</a></li><li><a class="nounderline abstract_t">Steiber A, Leon JB, Secker D, et al. Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population. J Ren Nutr 2007; 17:336.</a></li><li><a class="nounderline abstract_t">Cooper BA, Bartlett LH, Aslani A, et al. Validity of subjective global assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis 2002; 40:126.</a></li><li><a class="nounderline abstract_t">Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7:198.</a></li><li><a class="nounderline abstract_t">Kwon YE, Kee YK, Yoon CY, et al. Change of Nutritional Status Assessed Using Subjective Global Assessment Is Associated With All-Cause Mortality in Incident Dialysis Patients. Medicine (Baltimore) 2016; 95:e2714.</a></li><li><a class="nounderline abstract_t">Pifer TB, McCullough KP, Port FK, et al. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002; 62:2238.</a></li><li><a class="nounderline abstract_t">Moreau-Gaudry X, Jean G, Genet L, et al. A simple protein-energy wasting score predicts survival in maintenance hemodialysis patients. J Ren Nutr 2014; 24:395.</a></li><li><a class="nounderline abstract_t">Holvoet E, Vanden Wyngaert K, Van Craenenbroeck AH, et al. The screening score of Mini Nutritional Assessment (MNA) is a useful routine screening tool for malnutrition risk in patients on maintenance dialysis. PLoS One 2020; 15:e0229722.</a></li><li><a class="nounderline abstract_t">Chertow GM, Ackert K, Lew NL, et al. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. Kidney Int 2000; 58:2512.</a></li><li><a class="nounderline abstract_t">Cano N, Di Costanzo-Dufetel J, Calaf R, et al. Prealbumin-retinol-binding-protein-retinol complex in hemodialysis patients. Am J Clin Nutr 1988; 47:664.</a></li><li><a class="nounderline abstract_t">Chertow GM, Goldstein-Fuchs DJ, Lazarus JM, Kaysen GA. Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. Kidney Int 2005; 68:2794.</a></li><li><a class="nounderline abstract_t">Kalantar-Zadeh K, Kleiner M, Dunne E, et al. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis 1998; 31:263.</a></li><li><a class="nounderline abstract_t">Rambod M, Bross R, Zitterkoph J, et al. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009; 53:298.</a></li><li><a class="nounderline abstract_t">Iseki K, Yamazato M, Tozawa M, Takishita S. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 2002; 61:1887.</a></li><li><a class="nounderline abstract_t">Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995; 332:1758.</a></li><li class="breakAll">Lobo RA. Hormones, hormone replacement therapy, and heart disease. In: Cardiovascular Health and Disease in Women, Douglas PS (Ed), Saunders, Philadelphia 1993. p.153.</li><li><a class="nounderline abstract_t">Li TY, Rana JS, Manson JE, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006; 113:499.</a></li><li class="breakAll">http://www.who.int/nutrition/publications/obesity/WHO_report_waistcircumference_and_waisthip_ratio/en/.</li><li><a class="nounderline abstract_t">Sanches FM, Avesani CM, Kamimura MA, et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008; 52:66.</a></li><li><a class="nounderline abstract_t">Postorino M, Marino C, Tripepi G, et al. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53:1265.</a></li><li><a class="nounderline abstract_t">Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32:77.</a></li><li><a class="nounderline abstract_t">Chertow GM. Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time? J Ren Nutr 1999; 9:138.</a></li><li><a class="nounderline abstract_t">Stall S, Ginsberg NS, Lynn RI, Zabetakis PM. Bioelectrical impedance analysis and dual energy x-ray absorptiometry to monitor nutritional status. Perit Dial Int 1995; 15:S59.</a></li><li><a class="nounderline abstract_t">Erlichman M, Holohan TV. Bone densitometry: patients with end-stage renal disease. Health Technol Assess (Rockv) 1996; :1.</a></li><li><a class="nounderline abstract_t">Woodrow G, Oldroyd B, Smith MA, Turney JH. Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. Eur J Clin Nutr 1996; 50:295.</a></li><li><a class="nounderline abstract_t">Kamimura MA, Avesani CM, Cendoroglo M, et al. Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body fat in patients on long-term haemodialysis therapy. Nephrol Dial Transplant 2003; 18:101.</a></li><li><a class="nounderline abstract_t">Formica C, Atkinson MG, Nyulasi I, et al. Body composition following hemodialysis: studies using dual-energy X-ray absorptiometry and bioelectrical impedance analysis. Osteoporos Int 1993; 3:192.</a></li><li><a class="nounderline abstract_t">Sjöström L. A computer-tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int J Obes 1991; 15 Suppl 2:19.</a></li><li><a class="nounderline abstract_t">Martinson M, Ikizler TA, Morrell G, et al. Associations of body size and body composition with functional ability and quality of life in hemodialysis patients. Clin J Am Soc Nephrol 2014; 9:1082.</a></li><li><a class="nounderline abstract_t">Morrell GR, Ikizler TA, Chen X, et al. Psoas Muscle Cross-sectional Area as a Measure of Whole-body Lean Muscle Mass in Maintenance Hemodialysis Patients. J Ren Nutr 2016; 26:258.</a></li><li><a class="nounderline abstract_t">Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 2014; 9:1720.</a></li><li><a class="nounderline abstract_t">Vengata SUBRAMANI Manoharan, Jason IJ. Factors affecting hand grip strength and its evaluation: A systemic review. Int J Physiother Res 2015; 3:6.</a></li></ol></div><div id="topicVersionRevision">Topic 1850 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6794343" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6345902" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Assessment of nutritional status of the National Cooperative Dialysis Study population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8366899" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10435876" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Nutritional status of haemodialysis patients: a French national cooperative study. French Study Group for Nutrition in Dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8161729" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Lean body mass estimation by creatinine kinetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18094682" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2333868" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10505703" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Management of protein and energy intake in dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21115624" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Systemic consequences of poor oral health in chronic kidney disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8355451" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Serum albumin is a strong predictor of death in chronic dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7503074" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : A proposed glossary for dialysis kinetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12722026" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Obesity and survival on dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15755821" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Survival advantages of obesity in dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12723643" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Body mass index and mortality in asian populations: implications for obesity cut-points.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10354301" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Survival advantage in Asian American end-stage renal disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16129211" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16129211" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12324906" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Association of serum albumin and atherosclerosis in chronic hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15956056" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9159298" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Determinants of albumin concentration in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7814640" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8865921" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Factors affecting low values of serum albumin in CAPD patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4026190" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Albumin analysis in serum of haemodialysis patients: discrepancies between bromocresol purple, bromocresol green and electroimmunoassay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3698308" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Bromcresol purple method for serum albumin gives falsely low values in patients with renal insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8678068" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Comparison of methods for measuring albumin in peritoneal dialysis and hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/618669" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : New automated dye-binding method for serum albumin determination with bromcresol purple.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8430672" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Malnutrition in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2129442" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The protein catabolic rate as a measure of protein intake in dialysis patients: usefulness and limits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8592598" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Caloric rather than protein deficiency predominates in stable chronic haemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8856213" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10766003" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The dialysis outcomes quality initiative: history, impact, and prospects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10766003" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The dialysis outcomes quality initiative: history, impact, and prospects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3820522" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : What is subjective global assessment of nutritional status?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17720103" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12087570" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Validity of subjective global assessment as a nutritional marker in end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8785388" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26886609" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Change of Nutritional Status Assessed Using Subjective Global Assessment Is Associated With All-Cause Mortality in Incident Dialysis Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12427151" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25194620" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : A simple protein-energy wasting score predicts survival in maintenance hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32130271" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The screening score of Mini Nutritional Assessment (MNA) is a useful routine screening tool for malnutrition risk in patients on maintenance dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11115085" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3354492" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prealbumin-retinol-binding-protein-retinol complex in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16316355" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9469497" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19070949" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11967041" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7760894" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The primary prevention of coronary heart disease in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7760894" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The primary prevention of coronary heart disease in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16449729" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Obesity as compared with physical activity in predicting risk of coronary heart disease in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16449729" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Obesity as compared with physical activity in predicting risk of coronary heart disease in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18440683" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Waist circumference and visceral fat in CKD: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19358939" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4843734" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10431033" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7578489" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Bioelectrical impedance analysis and dual energy x-ray absorptiometry to monitor nutritional status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8722234" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Bone densitometry: patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8735310" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12480966" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body fat in patients on long-term haemodialysis therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8338974" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Body composition following hemodialysis: studies using dual-energy X-ray absorptiometry and bioelectrical impedance analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1794934" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A computer-tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24763868" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Associations of body size and body composition with functional ability and quality of life in hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26994780" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Psoas Muscle Cross-sectional Area as a Measure of Whole-body Lean Muscle Mass in Maintenance Hemodialysis Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25074839" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Comparative associations of muscle mass and muscle strength with mortality in dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Factors affecting hand grip strength and its evaluation: A systemic review</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
